510(k) device
PRIME-XV FreezIS DMSO-Free MD
Fujifilm Irvine Scientific · Media, Culture, Ex Vivo, Tissue And Cell (NDS, Class II) · First FDA decision Nov 9, 2023, newest Nov 9, 2023Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "PRIME-XV FreezIS DMSO-Free"
MAUDE reports
0
Brand "PRIME-XV FreezIS DMSO-Free", since 2015
PubMed studies
0
Mentioning "PRIME-XV FreezIS DMSO-Free"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing PRIME-XV FreezIS DMSO-Free MD
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K231804 · Decided Nov 9, 2023 · 142 days after receipt
Device type: Media, Culture, Ex Vivo, Tissue And Cell (NDS) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "PRIME-XV FreezIS DMSO-Free", any status and sponsor, newest update first.
No registered device study names "PRIME-XV FreezIS DMSO-Free".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "PRIME-XV FreezIS DMSO-Free", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NDS
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "PRIME-XV FreezIS DMSO-Free"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NDS.
- Msc SfmYocon Biology Technology Company · 510(k) 2024
- MoFi Cell Culture Basal MediumDuogenic Stemcells Corporation · 510(k) 2024
- Ct-StorEnergy Delivery Solutions · 510(k) 2021
- Optmizer Cts T-Cell Expansion Serum Free MediumLife Technologies, Inc. · 510(k) 2012
- Stempro Msc SfmLife Technologies Corporation · 510(k) 2011
- Knockout Sr Medium, Knockout Sr Xenofree Medium Model 10828, 12618Life Technologies Corporation · 510(k) 2010
- Aim-V (R) Medium, Model 087-0112Invitrogen Corporation · 510(k) 2002
- Dulbecco's Modified Eagle Medium (Dmem)Life Technologies, Inc. · De Novo 2001
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.